Here’s what you need to know.
1. Director of the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute at Cedars-Sinai and lead investigator Stephan Targan, MD, said the study is the “longest IBD study of its kind funded by the NIH and the first to explore the genetic makeup of the disease.”
2. The study started in 1992. Researchers have used molecular signatures to identify the several different types of IBD.
3. Dermot McGovern, MD, PhD, professor of Medicine and Biomedical Sciences and director of Cedars-Sinai Precision Health, said the project “is making very significant contributions to helping patients around the world.”
4. By establishing the molecular signatures, it positions researchers towards developing treatments for the disease to “finally bring relief and healing to many patients,” Dr. Targan said.
More articles on gastroenterology/endoscopy:
AGA releases animated video for GERD education: 3 highlights
Invendo receives CE Mark for sterile, single-use endoscope: 5 things you need to know
Allergan settles with Zydus and Cadila over Delzicol: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
